Literature DB >> 21663941

Breast cancer multifocality, disease extent, and survival.

Tibor Tot1, Mária Gere, Gyula Pekár, Miklós Tarján, Syster Hofmeyer, Dan Hellberg, David Lindquist, Tony Hsiu-His Chen, Amy Ming-Fang Yen, Sherry Yueh-Hsia Chiu, László Tabár.   

Abstract

The prognostic information implied in subgross morphologic parameters such as lesion distribution (unifocal, multifocal, or diffuse) and disease extent in breast cancer has remained largely unexplored in the literature. We aimed to test whether these parameters influence survival in breast carcinoma. The parameters were assessed in a series of 574 cases, all documented in large-format histology sections. We used Cox proportional hazards regression accompanied by Kaplan-Meyer survival curves, with P < .05 regarded as significant. The invasive component was unifocal in 62% (311/499), multifocal in 24% (122/499), and diffuse in 5% (26/499) of the cases. Combining the in situ and invasive tumor components resulted in 48% (274/574) unifocal, 25% (141/574) multifocal, and 20% (117/574) diffuse tumors. Sixty percent (347/574) of the tumors were categorized as having limited extent (occupying an area <40 mm in largest dimension) and 29% (164/574) as extensive. Highly significant (P < .0001) differences were observed in 10-year disease-specific cumulative survival among the cases with unifocal, multifocal, and diffuse invasive (89.6%, 76.0%, and 63.6%, respectively) and combined (92.3%, 82.3%, and 75.7%, respectively) lesion distribution. Patients with extensive tumors exhibited a significantly lower cumulative survival (P < .0001) compared with those with limited extent (91.6% and 75.5%) and a statistically significantly 1.89-fold (95% confidence interval, 1.07-3.37; P = .03) risk for breast cancer death after controlling for tumor attributes, type of surgery, and adjuvant therapy. The hazard ratio for breast cancer death for mutifocal and/or diffuse tumors versus unifocal ones was 1.96 (95%; 1.11-3.48; P = .02) after controlling for the same factors. Lesion distribution and disease extent represent important independent survival-related prognostic parameters in breast carcinoma.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21663941     DOI: 10.1016/j.humpath.2011.02.002

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  27 in total

1.  Which factors influence MRI-pathology concordance of tumour size measurements in breast cancer?

Authors:  M Rominger; D Berg; T Frauenfelder; A Ramaswamy; N Timmesfeld
Journal:  Eur Radiol       Date:  2015-08-14       Impact factor: 5.315

2.  Prognostic impact of multifocal and multicentric breast cancer versus unifocal breast cancer.

Authors:  Atsushi Fushimi; Atsushi Yoshida; Hiroshi Yagata; Osamu Takahashi; Naoki Hayashi; Koyu Suzuki; Hiroko Tsunoda; Seigo Nakamura; Hideko Yamauchi
Journal:  Surg Today       Date:  2018-10-13       Impact factor: 2.549

Review 3.  Is breast conservative surgery a reasonable option in multifocal or multicentric tumors?

Authors:  Gilles Houvenaeghel; Agnès Tallet; Aurélie Jalaguier-Coudray; Monique Cohen; Marie Bannier; Camille Jauffret-Fara; Eric Lambaudie
Journal:  World J Clin Oncol       Date:  2016-04-10

4.  Histopathological growth distribution of ductal carcinoma in situ: tumor size is not "one size fits all".

Authors:  Thomas J O'Keefe; Olivier Harismendy; Anne M Wallace
Journal:  Gland Surg       Date:  2022-02

Review 5.  The lobar approach to breast ultrasound imaging and surgery.

Authors:  Dominique Amy; Enzo Durante; Tibor Tot
Journal:  J Med Ultrason (2001)       Date:  2015-04-02       Impact factor: 1.314

6.  Clinical implications of multifocality as a prognostic factor in breast carcinoma - a multivariate analysis study comprising 460 cases.

Authors:  Monica Boros; Septimiu Voidazan; Cosmin Moldovan; Rares Georgescu; Cornelia Toganel; Denisa Moncea; Claudiu V Molnar; Cristian Podoleanu; Alexandru Eniu; Simona Stolnicu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 7.  The sick lobe hypothesis, field cancerisation and the new era of precision breast surgery.

Authors:  Mona P Tan; Tibor Tot
Journal:  Gland Surg       Date:  2018-12

Review 8.  The new TNM-based staging of breast cancer.

Authors:  Gábor Cserni; Ewa Chmielik; Bálint Cserni; Tibor Tot
Journal:  Virchows Arch       Date:  2018-01-27       Impact factor: 4.064

9.  Diffuse invasive breast carcinoma of no special type.

Authors:  Tibor Tot
Journal:  Virchows Arch       Date:  2015-10-31       Impact factor: 4.064

10.  The subgross morphology of breast carcinomas: a single-institution series of 2033 consecutive cases documented in large-format histology slides.

Authors:  Tibor Tot; Maria Gere; Syster Hofmeyer; Annette Bauer; Ulrika Pellas
Journal:  Virchows Arch       Date:  2019-08-13       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.